LEADER 01453nam  2200409z- 450 
001 9910694194603321
005 20220628191519.0
035   $a(BIP)042477162
035   $a(CKB)5860000000030707
035   $a(EXLCZ)995860000000030707
100   $a20220406c2005uuuu  -u-         -
101 0 $aeng
200 10$aOxycontin and beyond $eexamining the role of FDA and DEA in regulating prescription painkillers : hearing before the Subcommittee on Regulatory Affairs of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, September 13, 2005
215   $a1 online resource (iii, 127 p.) 
311   $a0-16-076799-7 
517   $aOxycontin and Beyond
606   $aOxycodone$xGovernment policy$zUnited States
606   $aAnalgesics$xGovernment policy$zUnited States
606   $aPharmaceutical policy$zUnited States
606   $aDrugs of abuse$xGovernment policy$zUnited States
610   $aAnalgesics
610   $aPharmaceutical policy
610   $aDrug abuse
610   $aMedical
610   $aPolitical science
610   $aPsychology
615  0$aOxycodone$xGovernment policy
615  0$aAnalgesics$xGovernment policy
615  0$aPharmaceutical policy
615  0$aDrugs of abuse$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bDLC
906   $aBOOK
912   $a9910694194603321
996   $aOxycontin and beyond$93220052
997   $aUNINA